Iron oxide(II,III), magnetic nanoparticles solution
ALDRICH/700312 - 10 nm avg. part. size, 5 mg/mL in toluene
Synonym: Magnetic iron oxide nanocrystals; Magnetite; Superparamagnetic iron oxide nanoparticles
CAS Number: 1317-61-9
Empirical Formula (Hill Notation): Fe3O4
Molecular Weight: 231.53
MDL Number: MFCD00011010
Linear Formula: Fe3O4
Product Type: Chemical
avg. part. size | 10 nm |
concentration | 5 mg/mL in toluene |
density | 0.865 g/mL at 25 °C |
form | nanoparticles |
solution | |
InChI | 1S/3Fe.4O |
InChI key | SZVJSHCCFOBDDC-UHFFFAOYSA |
magnetization | >45 emu/g (at ambient temperature under 4500 Oe) |
particle size | 9-11 nm (TEM; conforms) |
SMILES string | O=[Fe].O=[Fe]O[Fe]=O |
Application: | Fe3O4 can be used in the targeting and imaging of tumor cells for cancer therapy-based applications. It may also be used in the separation of tumor cells from fresh whole blood. It can also be used as an effective material in drug delivery systems and magnetic resonance imaging (MRI). |
General description: | Concentration 5mg/ml includes total weight nanocrystals plus ligands. |
General description: | Iron oxide(II,III), magnetic nanoparticles solution (Fe3O4) is an organic solvent dispersed nanoparticle solution, which can be synthesized by the thermal decomposition of iron acetylacetonate in 2-pyrrolidone. It is majorly used in biomedical applications due to its magnetic properties, particle size, and surface properties. It contains <1.0% oleic acid stabilizing ligands. |
Packaging: | 5 mL in glass bottle |
Symbol | GHS02,GHS07,GHS08 |
Signal word | Danger |
Hazard statements | H225 - H304 - H315 - H336 - H361d - H373 - H412 |
Precautionary statements | P201 - P210 - P273 - P301 + P310 - P303 + P361 + P353 - P331 |
Hazard Codes | F,Xn |
Risk Statements | 63-11-38-48/20-65-67 |
Safety Statements | 16-36/37-62 |
RIDADR | UN1294 - class 3 - PG 2 - Toluene, solution |
WGK Germany | WGK 2 |
Flash Point(F) | 45.0 °F |
Flash Point(C) | 7.2 °C |
Density | 0.865 g/mL at 25 °C |
UNSPSC | 12352302 |